Global Breast Cancer Treatment Market By Therapy (Targeted Therapy (Trastuzumab, Ribociclib, Pertuzumab, Palbociclib, Olaparib, Everolimus, Ado-Trastuzumab Emtansine, Abemaciclib, and Others), Hormonal Therapy (Selective Estrogen Receptor Modulators (SERMs), Estrogen Receptor Down Regulators (ERDs), and Aromatase Inhibitors), Chemotherapy, and Immunotherapy), By Cancer Type (Hormone Receptor and HER2+), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034